Product image of Lenzetto (Estradiol) supplied by GNH India

Lenzetto

Active Ingredient:
Estradiol
Origin:
EU

Lenzetto (Estradiol)

Estradiol, the active ingredient in Lenzetto, is an estrogen presented as a transdermal patch for transdermal use. It is indicated for relief of menopausal vasomotor symptoms, correction of estrogen deficiency, and prevention of osteoporosis in postmenopausal women.

GNH India supplies Lenzetto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable cold‑chain logistics where required. Our distribution network ensures timely delivery and regulatory documentation for import and resale globally.

Manufacturer / TM Owner

Gedeon Richter Polska Sp. Z. O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lenzetto is used in hormone replacement therapy to address estrogen‑related conditions.
  • Menopausal vasomotor symptoms: reduces the frequency and severity of hot flashes, night sweats and improves overall comfort during menopause.
  • Estrogen deficiency: restores systemic estrogen levels, alleviating symptoms such as vaginal dryness, mood swings and fatigue in postmenopausal women.
  • Prevention of osteoporosis: increases bone mineral density, thereby lowering the risk of fractures associated with postmenopausal bone loss.

How It Works

  • Estradiol in Lenzetto penetrates the skin and enters systemic circulation, where it binds to intracellular estrogen receptors (ERα and ERβ). Receptor activation induces conformational changes that allow the receptor‑ligand complex to bind estrogen‑responsive elements on DNA, modulating transcription of target genes involved in thermoregulation, bone remodeling, and reproductive tissue maintenance. These genomic actions restore estrogen‑dependent physiological pathways and contribute to symptom relief and bone health.

Side Effects

Lenzetto may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Skin irritation at patch site: redness, itching or rash where the patch is applied.
  • Headache: mild to moderate tension‑type headaches.
  • Nausea: transient feeling of stomach upset.
  • Breast tenderness: mild swelling or discomfort in breast tissue.

Serious or Rare Side Effects

  • Thromboembolic events: deep vein thrombosis or pulmonary embolism.
  • Stroke or transient ischemic attack: cerebrovascular accidents.
  • Myocardial infarction: heart attack risk may increase.
  • Severe allergic reaction: anaphylaxis, angioedema or hives.

Precautions & Warnings

Before prescribing Lenzetto, clinicians should evaluate patient risk factors and follow safety guidelines.

  • Cardiovascular assessment: review history of thromboembolism, stroke or coronary artery disease.
  • Breast cancer screening: consider prior or current estrogen‑dependent malignancies.
  • Liver function monitoring: check hepatic impairment that may alter estradiol metabolism.
  • Bone health evaluation: assess baseline bone mineral density in osteoporosis prevention.
  • Concomitant estrogen use: avoid combining with other systemic estrogen products.
  • Store at room temperature: keep the patch in its original pouch, protect from moisture and direct sunlight.

Avoid Interactions

Estradiol may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Warfarin: increased anticoagulant effect leading to bleeding risk.
  • Oral contraceptives containing estrogen: additive estrogen exposure may raise thrombotic risk.
  • Tamoxifen: antagonistic effect reduces tamoxifen efficacy in breast cancer treatment.

Moderate Interactions (Monitor Closely)

  • Antiepileptic drugs (e.g., carbamazepine, phenytoin): may decrease estradiol plasma levels.
  • Selective serotonin reuptake inhibitors (e.g., fluoxetine): can increase estradiol concentrations and side‑effect potential.

Frequently Asked Questions

Lenzetto is a prescription transdermal patch that delivers estradiol, an estrogen, to treat menopausal vasomotor symptoms such as hot flashes, to correct estrogen deficiency in postmenopausal women, and to help prevent osteoporosis by supporting bone mineral density.

Estradiol binds to intracellular estrogen receptors (ERα and ERβ) after being absorbed through the skin. The activated receptor complex interacts with DNA at estrogen‑responsive elements, regulating the transcription of genes that control temperature regulation, bone remodeling, and the health of reproductive tissues.

The specific dose and patch change interval are determined by the prescribing clinician based on the individual’s age, severity of symptoms, and overall health. Lenzetto is supplied as a pre‑measured transdermal patch, and the prescriber will indicate how often the patch should be applied.

Lenzetto is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy because estrogen can cause fetal harm. It is also not recommended during breastfeeding, as estradiol may pass into breast milk and affect the infant.

To request Lenzetto, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with oral estradiol tablets, the transdermal patch bypasses first‑pass hepatic metabolism, potentially reducing liver‑related side effects and providing more stable serum estradiol levels. Relative to other patches (e.g., Estradot), Lenzetto offers comparable efficacy; selection often depends on dosing convenience, skin tolerance and local regulatory approvals.

Store Lenzetto at room temperature, preferably below 25 °C, in its original pouch. Keep the patch away from moisture, direct sunlight and heat sources. Do not refrigerate or freeze the product, and handle with clean, dry hands to avoid contaminating the adhesive surface.

The patch is applied to clean, dry, hair‑free skin on the abdomen, buttock, or upper arm. Press firmly for several seconds to ensure adhesion, then replace the patch according to the prescriber’s schedule—typically once weekly. Rotate application sites to minimize skin irritation.

Serious risks include thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, cerebrovascular accidents (stroke or TIA), myocardial infarction, and severe allergic reactions like anaphylaxis. Patients with a history of clotting disorders, cardiovascular disease, or estrogen‑dependent cancers should be monitored closely.

Lenzetto is contraindicated in individuals with known or suspected estrogen‑dependent malignancies (e.g., breast or endometrial cancer), active or past thromboembolic disease, uncontrolled hypertension, liver disease, or in women who are pregnant or breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Estradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT